Stick With Shoppers

Shoppers’ shares took a recent hit but the long term prospects are well entrenched for this dominant Canadian retailer.

Shoppers Drug Mart (TSX:SC), one of this country’s most recognized retailers, had 5% or so carved from its market capitalization on Friday.  The market was reacting to news that provincial governments agreed to cap the price on six of Canada’s most popular generic drugs at 18% of the equivalent brand name price.  Prior to this announcement, these generic drugs had sold at 25-40% of their branded equivalents.

The move is a cost saving measure for the provinces, who along with private health plans, account for a very large majority of prescription drug purchases in Canada.  It is expected that the cap will save the provinces about $100 million per year and of course negatively impact pharmacies by a similar amount.

A drop in the shopping cart

Shoppers had combined revenues of $10.7 billion over the past four reporting periods.  Even if it filled every prescription in the country, a $100 million annual hit is hardly material and therefore unlikely to be the reason for the January 18th decline.  The decline can more likely be attributed to the reintroduction of headline risk for Canadian pharmacies and the possibility that further announcements could turn this $100 million into a much bigger number.

The industry, and Shoppers’ shares, faced a considerable headwind in the spring of 2010 when the province of Ontario announced a sweeping reform to its drug system.  The news cut Shoppers earnings multiple from the 16-17 range that it had been trading in to 13.  Although regulatory risk has been an undertone since the 2010 Ontario decision, Shoppers multiple had drifted back into the range of 15.  The recent announcement served as a reminder that the provinces remain a risk to this story and a multiple closer to 13 or 14 may be more appropriate for Shoppers at this time.

Keep calm and invest on

For current shareholders, don’t panic.  While these provincial actions are likely to have an impact on the company’s near term growth, longer term it is tough to find a story that makes more sense.  The company is financially sound, pays a nice dividend that has grown steadily, and has great prospects for future growth.  Currently 14.4% of Canadians are 65 and over.  By 2026, this figure is expected to move to 20%.  More than 6 million Canadians will be in their prime (prescription) drug taking years.  There are few Canadian companies as well positioned to play the ageing demographic card as Shoppers.  Once the reform is complete, the combination of pricing certainty and a highly favourable demographic should be very rewarding for long term owners of Shoppers Drug Mart.  This is not a name that you should run away from.

Follow us on Twitter for the latest in Foolish investing.

Fool contributor Iain Butler does not own shares in any of the companies mentioned in this post.  The Motley Fool has no positions in the stocks mentioned above.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

More on Investing

money cash dividends
Stocks for Beginners

The Best Stocks to Buy With $500 Right Now

Do you have $500 to spare after your Christmas shopping? Here are three top Canadian stocks that are primed to…

Read more »

tsx today
Energy Stocks

TSX Today: What to Watch for in Stocks on Thursday, December 8

TSX stocks may remain volatile ahead of the U.S. inflation data and the Fed’s interest rate decision, which are due…

Read more »

Dividend Stocks

Enbridge Is a High-Yielding Canadian Dividend Stock to Buy Now and Own Forever

Are you looking for a high-yielding Canadian dividend stock to buy? Enbridge (TSX:ENB) has plenty to offer investors.

Read more »

sale discount best price
Stocks for Beginners

3 TSX Growth Stocks You Can Buy at a Screaming Discount

These three growth stocks remain screaming buys, given their track records of growth and future opportunities for investors.

Read more »

Retirees sip their morning coffee outside.
Dividend Stocks

Why I’d Buy These 2 Healthcare Stocks Today (Besides the Cheap $10 Price)

Two small-cap stocks trading under $10 worth buying right now as promising healthcare plays in 2023.

Read more »

woman data analyze

Better Buy: Telus Stock or BCE?

Telus (TSX:T) and BCE (TSX:BCE) are dividend-growth stocks that seem like worthy pick-ups ahead of a recession year.

Read more »

Silver coins fall into a piggy bank.
Dividend Stocks

3 Dividend Stocks to Build Wealth in the New Year

These dividend stocks have proven they're set up for a strong future and have dividends you'll want to lock up…

Read more »

Dad and son having fun outdoor. Healthy living concept
Tech Stocks

Prediction: These Will Be 2 of the Strongest TSX Stocks in 2023

Tech stocks may have dropped during the last few years, but these two TSX stocks are bound for major growth…

Read more »